Screener
Ionis Pharmaceuticals IONS Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's return on invested capital?
- Ionis Pharmaceuticals (IONS) reported return on invested capital of -80.3% in Q2 2026.
- How has Ionis Pharmaceuticals's return on invested capital changed year-over-year?
- Ionis Pharmaceuticals's return on invested capital decreased by 97.2% year-over-year, from -40.7% to -80.3%.
- What is the long-term trend for Ionis Pharmaceuticals's return on invested capital?
- Over 3 years (2020 to 2025), Ionis Pharmaceuticals's return on invested capital has grown at a 5.8% compound annual growth rate (CAGR), from -20.4% to -24.2%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Ionis Pharmaceuticals's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude